Evidence map›Paper›PMID 39438804›Full record

ArticleBMC microbiology2024

High prevalence of ESBL-producing E. coli phylogroup B2 clinical isolates in northeastern Thailand.

Sumontha Chaisaeng, Peechanika Chopjitt, Pachara Kasemsiri, Nuntiput Putthanachote, Parichart Boueroy, Dan Takeuchi, Yukihiro Akeda, Sihigeyuki Hamada, Anusuk Kerdsin

Abstract read
In one paragraph

Article in BMC microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Tracking Extended-Spectrum β-Lactamase-ProducingAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Antimicrobial Resistance Patterns of ESBL-ProducingAntibiotics (Basel, Switzerland) · 2025
    Article
  11. Article
  12. Limited clonality but widespread plasmid sharing of ESBL-producingCurrent research in microbial sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sumontha ChaisaengFaculty of Public Health, Kasetsart University Chalermphrakiat, Sakon Nakhon Campus, Sakon, Nakhon, Thailand.
Peechanika ChopjittFaculty of Public Health, Kasetsart University Chalermphrakiat, Sakon Nakhon Campus, Sakon, Nakhon, Thailand. peechanika.c@ku.th.
Pachara KasemsiriClinical Microbiology Laboratory, Sakon Nakhon Hospital, Sakon Nakhon, Thailand.
Nuntiput PutthanachoteClinical Microbiology Laboratory, Roi-Et Hospital, Roi Et, Thailand.
Parichart BoueroyFaculty of Public Health, Kasetsart University Chalermphrakiat, Sakon Nakhon Campus, Sakon, Nakhon, Thailand.
Dan TakeuchiJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Thailand.
Yukihiro AkedaJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Thailand.
Sihigeyuki HamadaJapan-Thailand Research Collaboration Center on Emerging and Re-Emerging Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Thailand.
Anusuk KerdsinFaculty of Public Health, Kasetsart University Chalermphrakiat, Sakon Nakhon Campus, Sakon, Nakhon, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProduction of extended-spectrum β-lactamases (ESBLs) is a common resistance mechanism in Enterobacteriaceae, leading to serious hospital-acquired infections. This study aimed to assess phenotypic, phylogenetic, and antibiotic resistance patterns among ESBL-producing Escherichia coli isolates recovered from two rural tertiary hospitals in Thailand.

resultsAmong 467 Enterobacteriaceae isolates, E. coli was the most prevalent 356 (76.2%) followed by K. pneumoniae 88 (18.8%), K. aerogenes 8 (1.7%), K. variicola 3 (0.6%), K. quasipneumoniae 1 (0.2%%), K. oxytoca 1 (0.2%), and unidentified 9 (1.9%). Of the 202 cephalosporin-resistant E. coli isolates, 195 (96.5%) were ESBL-producing and 7 (3.5%) were non-ESBL-producing. Clermont typing revealed that phylogroup B2 was predominant (43.3%), followed by phylogroups F (11.3%), D (10.3%), C (9.7%), and A (8.7%). Among the beta-lactamase-encoding genes, bla

conclusionOur findings show that phylogroup B2 was the most prevalent phylogroup among ESBL-producing E. coli isolates in northeastern Thailand. Notably, the isolates mostly carried the bla

Indexed as

Anti-Bacterial Agentsbeta-LactamasesEscherichia coliEscherichia coli InfectionsDrug Resistance, Multiple, BacterialHumansMicrobial Sensitivity TestsPhylogenyPrevalenceTertiary Care CentersThailandAnti-Bacterial Agentsbeta-LactamasesblaCTX-MClermont typingE. coliExtended-spectrum β-lactamaseThird-generation cephalosporin resistance

Identifiers

PMID39438804
PMCPMC11495076

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.